Wave Life Sciences (WVE) FCF Margin Growth (1y) (2016 - 2026)
Wave Life Sciences (WVE) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 53,202.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,202.00 |
| Jun 30, 2025 | -39,270.00 |
| Mar 31, 2025 | -41,890.00 |
| Jun 30, 2024 | 2,911.00 |
| Mar 31, 2024 | -92,766.00 |
| Dec 31, 2023 | 259,979.00 |
| Sep 30, 2023 | 908,853.00 |
| Jun 30, 2023 | 764,820.00 |
| Mar 31, 2023 | 294,803.00 |
| Dec 31, 2022 | -231,610.00 |
| Sep 30, 2022 | -908,130.00 |
| Jun 30, 2022 | -746,620.00 |
| Dec 31, 2021 | -6,060.00 |
| Sep 30, 2021 | 50,893.00 |
| Jun 30, 2021 | 91,379.00 |
| Dec 31, 2020 | 226,903.00 |
| Sep 30, 2020 | 92,062.00 |
| Jun 30, 2020 | -81,200.00 |
| Mar 31, 2020 | 103,693.00 |
| Dec 31, 2019 | -160,546.00 |